Epidemiology of Neurological Disease

Jun Lee^*
*Correspondence: Jun Lee, Department of Neurology, Sungkyunkwan University, Changwon, South Korea, Email:

Keywords

Epilepsy • Parkinson's disease • Medications • Epidemiology • Diagnosis

Introduction

Epilepsy is a neurological condition characterized by recurrent seizures. According to the WHO, epilepsy affects approximately 50 million people worldwide, and is more common in low- and middle-income countries. Parkinson's disease is a progressive neurological condition that affects movement and can cause a range of motor and non-motor symptoms. According to the Parkinson's Foundation, approximately one million Americans are living with Parkinson's disease. Multiple sclerosis is a chronic autoimmune condition that affects the central nervous system. According to the National Multiple Sclerosis Society, approximately one million people in the United States are living with multiple sclerosis. Neurological diseases can have a significant impact on individuals and their families, as well as on society as a whole. The burden of neurological disease can be measured in a variety of ways, including mortality, morbidity, and economic cost. Neurological diseases are a leading cause of death worldwide. According to the WHO, stroke is responsible for 11% of all deaths worldwide, and other neurological conditions such as Parkinson's disease and motor neuron disease can also contribute to mortality [1].

Literature Review

According to a report from the Institute of Medicine, the total annual cost of neurological diseases in the United States is estimated to be between $400 billion and $500 billion. The economic cost of neurological diseases can be further broken down into direct and indirect costs. Direct costs include healthcare costs such as hospitalizations, medications, and physician visits, while indirect costs include lost productivity due to disability and premature death. Prevention and management of neurological disease is a key public health priority. Strategies for prevention and management vary depending on the specific condition. Vaccination can help prevent certain neurological conditions such as meningitis and encephalitis. Lifestyle modifications such as regular exercise, a healthy diet, and avoiding tobacco and excessive alcohol use can help reduce the risk of certain neurological conditions such as stroke and dementia. Stroke is a leading cause of death and disability worldwide, and is caused by a disruption of blood flow to the brain [2].

Discussion

Neurological diseases are a significant public health concern worldwide, affecting millions of people and causing significant disability and mortality. Epidemiology is the study of the distribution and determinants of health and disease in populations, and it plays an important role in understanding the burden of neurological diseases. In this article, we will explore the epidemiology and burden of neurological diseases. Prevalence refers to the proportion of a population that has a specific disease or condition at a given point in time, while incidence refers to the number of new cases of a disease or condition that occur in a population over a specified period of time. Neurological diseases are among the leading causes of disability and death worldwide, and their prevalence and incidence vary widely depending on the disease and the population studied. For example, Alzheimer's disease, the most common form of dementia, affects an estimated 50 million people worldwide, while multiple sclerosis affects an estimated 2.5 million people worldwide [3].

Neurological diseases are also a significant cause of mortality worldwide. For example, stroke is the second leading cause of death globally, responsible for an estimated 5.5 million deaths in 2016. Other neurological diseases that contribute to mortality include Parkinson's disease, motor neuron disease, and traumatic brain injury. Neurological diseases can cause significant disability, impacting an individual's ability to perform daily activities and participate in society. Neurological diseases can have a significant impact on quality of life, and can result in disability and dependence. For example, Alzheimer's disease and other dementias can result in cognitive decline and loss of functional abilities, while Parkinson's disease can cause motor symptoms such as tremors and rigidity. These conditions are more common in older adults, and are a leading cause of disability worldwide. Neurological diseases can also have a significant economic impact, both in terms of healthcare costs and lost productivity. According to the WHO, stroke is responsible for 11% of all deaths worldwide. Alzheimer's disease and other dementias: Alzheimer's disease and other dementias are progressive neurological conditions that affect cognitive function [4].

The disability burden of neurological diseases can be measured using disability-adjusted life years which combine years of life lost due to premature death with years lived with disability. For example, dementia was responsible for 15.4 million DALYs globally in 2016, while stroke was responsible for 116.4 million DALYs globally in the same year. Understanding the risk factors for neurological diseases is important for developing strategies for prevention and treatment. Risk factors for neurological diseases can be divided into modifiable and non-modifiable factors. Modifiable risk factors include lifestyle factors such as smoking, alcohol consumption, physical inactivity, and poor diet, as well as medical conditions such as hypertension, diabetes, and high cholesterol. Nonmodifiable risk factors include age, genetics and family history. Neurological diseases can also have a disproportionate impact on certain populations, including those in low- and middle-income countries, older adults and minority populations. For example, stroke incidence and mortality are higher in lowand middle-income countries compared to high-income countries and African Americans have a higher incidence of stroke compared to other racial/ethnic groups in the United States [5].

Many neurologists in neuro-oncology are involved in clinical research and as such, they must have strong research skills, including the ability to design and conduct studies, analyze data, and communicate findings to other researchers and clinicians. Neurologists in neuro-oncology must be able to communicate effectively with patients and their families, explaining complex medical information in a clear and understandable way and providing emotional support throughout the treatment process. Brain and spinal cord tumors can be complex and difficult to diagnose and treat, requiring a multidisciplinary approach and advanced technologies such as stereotactic radiosurgery and intraoperative imaging [6].

Conclusion

Epidemiological research on neurological diseases faces several challenges, including difficulties in accurate diagnosis and classification of neurological diseases, the heterogeneity of neurological diseases, and the long latency period between exposure to risk factors and the development of neurological diseases. In addition, there is often a lack of standardized data collection and reporting, making it difficult to compare data across studies and countries. Effective public health interventions can play a critical role in reducing the burden of neurological diseases. Prevention efforts can target modifiable risk factors such as smoking, physical inactivity and poor diet, as well as medical conditions such as hypertension, diabetes and high cholesterol. Screening and early detection can also help identify individuals at risk for neurological diseases, allowing for early intervention and treatment. In addition, public health interventions can focus on improving access to care and support for individuals with neurological diseases, as well as promoting research to better understand the underlying mechanisms and risk factors for neurological diseases.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Koerbes, Ana Paula, Franceli Rodrigues Kulcheski, Rogerio Margis and Marcia Margis-Pinheiro, et al. "Molecular evolution of the Lysophosphatidic Acid Acyltransferase (LPAAT) gene family."Mol Phylogenet Evol 96 (2016): 55-69.

Google Scholar, Crossref, Indexed at

2. Yan, Liwei, Zhi Yao, Tao Lin and Qingtang Zhu, et al. "The role of precisely matching fascicles in the quick recovery of nerve function in long peripheral nerve defects."Neuroreport28 (2017): 1008.

Google Scholar, Crossref, Indexed at

3. Zhang, Xiao-Qin, Ze-Lin Wang, Ming-Wai Poon and Jian-Hua Yang. "Spatial-temporal transcriptional dynamics of long non-coding RNAs in human brain."Hum Mol Genet 26 (2017): 3202-3211.

Google Scholar, Crossref, Indexed at

4. Qi, Jian, Wei-Ya Wang, Ying-Chun Zhong and Jia-Ming Zhou, et al. "Three-dimensional visualization of the functional fascicular groups of a long-segment peripheral nerve."Neural Regen Res 13 (2018): 1465.

Google Scholar, Crossref, Indexed at

5. Liu, Jiang-Hui, Qing Tang, Xiang-Xia Liu and Jian Qi, et al. "Analysis of transcriptome sequencing of sciatic nerves in Sprague-Dawley rats of different ages."Neural Regen Res 13 (2018): 2182.

Google Scholar, Crossref, Indexed at

6. Pessoa, Luiz. "Understanding emotion with brain networks."Curr Opin Behav Sci 19 (2018): 19-25.

Google Scholar, Crossref, Indexed at